Skip to main content
CellSeed Inc. logo

CellSeed Inc. — Investor Relations & Filings

Ticker · 7776 ISIN · JP3423530009 T Manufacturing
Open in API
Filings indexed 65 across all filing types
Latest filing 2020-08-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 7776

About CellSeed Inc.

https://www.cellseed.com/en/

CellSeed Inc. is a regenerative medicine company centered on the research, development, and commercialization of its proprietary "cell sheet engineering" technology. This innovative platform enables the creation and harvesting of intact sheets of cultured cells without enzymatic treatment, preserving the extracellular matrix and cell-to-cell junctions critical for therapeutic efficacy. The company's business is structured around three core activities: the development of its own pipeline of cell sheet-based therapies for tissue regeneration, the sale of specialized temperature-responsive cell cultureware and related equipment, and the provision of contract development and manufacturing (CDMO) services for regenerative medicine products.

Recent filings

Filing Released Lang Actions
四半期報告書－第20期第2四半期(令和2年4月1日－令和2年6月30日)
Interim / Quarterly Report
2020-08-14 Japanese
四半期報告書－第20期第1四半期(令和2年1月1日－令和2年3月31日)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) filed by CellSeed Inc. in Japan. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement for the first quarter of 2020. It is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-15 Japanese
有価証券報告書－第19期(平成31年1月1日－令和1年12月31日)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the standard annual financial filing required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, management discussion, and corporate information for the fiscal year ending December 31, 2019. This corresponds to the 10-K equivalent in the provided classification schema. FY 2019
2020-03-30 Japanese
四半期報告書－第19期第3四半期(2019/07/01－2019/09/30)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for the third quarter of the 19th fiscal period (2019) for CellSeed Inc. It contains detailed financial statements, management analysis (MDA), and business status updates, which are characteristic of an interim/quarterly financial report. It is not an announcement of a report, but the report itself, and it contains substantive financial data. Q3 2019
2019-11-14 Japanese
四半期報告書－第19期第2四半期(2019/04/01－2019/06/30)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for CellSeed Inc. covering the second quarter of 2019. It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement, as well as management's analysis of financial results. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2019
2019-08-14 Japanese
四半期報告書－第19期第1四半期(2019/01/01－2019/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for the first quarter of 2019, filed by CellSeed Inc. with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, including the balance sheet, income statement, and segment information, as well as management's analysis of the financial results. This fits the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-15 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.